PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Humabs BioMed SA, Vir Biotechnology, Bellinzona, Switzerland.\', \'Department of Biochemistry, University of Washington, Seattle, WA, USA.\', \'Institut Pasteur and CNRS UMR 3569, Unité de Virologie Structurale, Paris, France.\', \'Vir Biotechnology, San Francisco, CA, USA.\', \'Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.\', \'Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.\', \'Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.\', \'Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.\', \'Department of Biochemistry, University of Washington, Seattle, WA, USA. dveesler@uw.edu.\', \'Humabs BioMed SA, Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41586-020-2349-y
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 32422645
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32422645>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32422645>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all